Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Artichoke leave extract for chronic hepatitis C - a pilot study.

Huber R, Müller M, Naumann J, Schenk T, Lüdtke R.

Phytomedicine. 2009 Sep;16(9):801-4. doi: 10.1016/j.phymed.2009.03.007. Epub 2009 May 8.

PMID:
19427774
2.

Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.

Huber R, Lüdtke R, Klassen M, Müller-Buscher G, Wolff-Vorbeck G, Scheer R.

Eur J Med Res. 2001 Sep 28;6(9):399-405.

PMID:
11669085
3.

Birch bark extract as therapy for chronic hepatitis C--a pilot study.

Shikov AN, Djachuk GI, Sergeev DV, Pozharitskaya ON, Esaulenko EV, Kosman VM, Makarov VG.

Phytomedicine. 2011 Jul 15;18(10):807-10. doi: 10.1016/j.phymed.2011.01.021. Epub 2011 Mar 5.

PMID:
21377854
4.

Does Silybum marianum play a role in the treatment of chronic hepatitis C?

Torres M, Rodríguez-Serrano F, Rosario DJ, Rodríguez-Perez F, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):69-74.

PMID:
16929590
5.

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJ, Roberts SK.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):275-80.

PMID:
16460486
6.

Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels.

Kronenberger B, Rüster B, Lee JH, Sarrazin C, Roth WK, Herrmann G, Zeuzem S.

J Hepatol. 2000 Oct;33(4):640-7.

PMID:
11059870
7.

Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens.

Huber R, Futter I, Lüdtke R.

Eur J Med Res. 2005 Feb 28;10(2):68-70.

PMID:
15817425
8.

Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.

Cadranel JF, Di Martino V, Dorent R, Bernard B, Hoang C, Myara A, Pauwels A, Ghoussoub JJ, Perrin M, Grippon P, Thabut D, Trivin F, Huraux JM, Gandjbakhch I, Opolon P, Lunel F.

Transplantation. 2003 Apr 15;75(7):977-82.

PMID:
12698083
9.

A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients.

Deng G, Kurtz RC, Vickers A, Lau N, Yeung KS, Shia J, Cassileth B.

J Ethnopharmacol. 2011 Jun 14;136(1):83-7. doi: 10.1016/j.jep.2011.04.008. Epub 2011 Apr 17.

PMID:
21527335
10.

Amantadine therapy in renal transplant patients with hepatitis C virus infection.

Kamar N, Rostaing L, Sandres-Saune K, Ribes D, Durand D, Izopet J.

J Clin Virol. 2004 May;30(1):110-4.

PMID:
15072764
12.

Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.

Crosignani A, Budillon G, Cimino L, Del Vecchio Blanco C, Loguercio C, Ideo G, Raimondo G, Stabilini R, Podda M.

Hepatogastroenterology. 1998 Sep-Oct;45(23):1624-9.

PMID:
9840118
13.

Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.

Chrétien P, Chousterman M, Abd Alsamad I, Ozenne V, Rosa I, Barrault C, Lons T, Hagège H.

J Autoimmun. 2009 May-Jun;32(3-4):201-5. doi: 10.1016/j.jaut.2009.02.005. Epub 2009 Mar 26.

PMID:
19324518
14.

Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C.

Shiffman ML, Pockros P, McHutchison JG, Schiff ER, Morris M, Burgess G.

Aliment Pharmacol Ther. 2010 May;31(9):969-78. doi: 10.1111/j.1365-2036.2010.04264.x. Epub 2010 Feb 16.

16.

Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study.

Chande N, Laidlaw M, Adams P, Marotta P.

Dig Dis Sci. 2006 Jul;51(7):1183-9.

PMID:
16944007
17.

Gamma-glutamyltransferase activity in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection.

Souza JF, Longui CA, Miorin LA, Sens YA.

Transplant Proc. 2008 Jun;40(5):1319-23. doi: 10.1016/j.transproceed.2008.03.157.

PMID:
18589096
18.

Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection.

Azocar J, Diaz A.

World J Gastroenterol. 2013 Feb 21;19(7):1085-90. doi: 10.3748/wjg.v19.i7.1085.

19.

Hormone therapy in Brazilian postmenopausal women with chronic hepatitis C: a pilot study.

Padua MA, Fonseca AM, Deguti MM, Bagnoli VR, Farias AQ, Maciel GA, Soares JM Jr, Carilho FJ, Baracat EC.

Climacteric. 2010 Apr;13(2):179-86. doi: 10.3109/13697130902952577.

PMID:
19657792
20.

DDB treatment of patients with chronic hepatitis.

Huber R, Hockenjos B, Blum HE.

Hepatology. 2004 Jun;39(6):1732-3.

PMID:
15185315

Supplemental Content

Support Center